Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 4;5(4):e437. doi: 10.1097/TXD.0000000000000876

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Percentage of gain in liver weight at the end of perfusion. Analysis of liver weight before and after NEsLP demonstrated a significantly lower percentage of weight gain in the grafts perfused with Steen and WB groups compared with the Gelofusine group (Steen, 4.62 ± 5.75%, Gelofusine, 14.73 ± 5.95%, WB, 5.73 ± 7.58%; P = 0.01). Results are expressed as mean ± SD. Six experiments were performed per group (n = 6). Student t test was used for analysis.NEsLP, normothermic ex situ liver perfusion; SD, standard deviation; WB, whole blood.